Neuroinv,
That tail wind of a resolution of Neurology's inquiry may be right, hopefully right, some investors might be waiting for that, but what in political garb is ever a clear resolution. Maybe there will be a press release stating "currently no further testing appears needed".
Avandia, celebrex, vioxx. More reasoning for a cloudy ending to the inquisition.
From what the FDA stated most recently, what would keep them from not issuing any additional statement that further trials will need special monitoring for certain symptoms or behaviors.
A CC announcing the IND and resummarizing the press releases made already/between now and then may be a good impact but but it also do nothing significant. After all, earlier this year Stoll made clear evidence pointed in their favor towards lifting the restrictions.
Weren't dealings on the table for a BP deal when the hold took place, the hold is off and in addition to all the hard work having taken place this year already, the possibility for things to happen in the doldrums of summer is there. After all, the guys on CNBC were saying that with the market downturn recently people were not going on their normal vacations :)
A BP deal would fit the timing, an IND would not, a resolution with that narrow time frame for release would not be right-better to receive the resolution information then set a date for a cc to thoroughly review it and the next steps to make.
Any good new information, a plus.
Market Data 
Markets 
AI
